IntegraGen S.A.
PAR: ALINT.PA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Euronext Paris
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Berengere Genin
- Employees
- 44
- Headquarters
- Évry, France
- IPO year
- 2010
- Market cap
- €1.6M
- Website
- https://integragen.com
Loading ALINT…
Loading profile data…Frequently asked questions about ALINT
What does IntegraGen S.A. (ALINT.PA) do?
IntegraGen SA provides human genome analysis services for academic researcher and life sciences companies in France. Its genomic services include transcriptomics, epigenomics, DNA sequencing, NGS testing for cancer research, and SNP genotyping. The company offers clinical research services, such as clinical grade sequencing and pharmacogenomics;...
Where does ALINT.PA trade?
IntegraGen S.A. (ALINT.PA) trades on the Euronext Paris.
What sector is ALINT.PA in?
IntegraGen S.A. (ALINT.PA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of IntegraGen S.A.?
Berengere Genin is the chief executive officer of IntegraGen S.A. (ALINT.PA).
Where is IntegraGen S.A. headquartered?
IntegraGen S.A. is headquartered in France.
Does ALINT.PA pay a dividend?
IntegraGen S.A. (ALINT.PA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ALINT.PA go public?
IntegraGen S.A. (ALINT.PA) completed its initial public offering in 2010.